Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387617103> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W4387617103 endingPage "3201" @default.
- W4387617103 startingPage "3201" @default.
- W4387617103 abstract "Next-generation sequencing (NGS) is widely used in muscle-invasive bladder cancer but has limited use in non-muscle-invasive bladder cancer (NMIBC) due to significant heterogeneity and high cancer-specific survival. Therefore, we evaluated the genomic information of NMIBC and identified molecular alterations associated with tumour recurrence. A total of 43 patients with NMIBC who underwent transurethral resection of the bladder were enrolled. We performed NGS using an Oncomine panel of tumour specimens and blood samples corresponding to each specimen. The somatic mutation results were analysed by pairwise comparison and logistic regression according to the recurrence of bladder tumours within 1 year. The median incidence of genetic variations in 43 tumour samples was 56 variations per sample, and a high tumour mutation burden (TMB) was associated with tumour recurrence (median variation 33 vs. 64, p = 0.023). The most mutated gene was adipose tissue macrophages (ATM) (79%), followed by neurofibromatosis-1 (NF1) (79%), and neurogenic locus notch homolog protein 1 (NOTCH1) (79%). In multivariable analysis, mutation of epidermal growth factor receptor (EGFR) (odds ratio [OR], 9.95; 95% confidence interval [CI], 1.40–70.96; p = 0.022) and telomerase reverse transcriptase (TERT) (OR, 7.92; 95% CI, 1.22–51.51; p = 0.030) were significant factors associated with the recurrence of bladder tumour within 1 year. Our results revealed that high TMB, EGFR mutation, and TERT mutation had a significant association with tumour recurrence in NMIBC. In addition, somatic mutations in EGFR and TERT could be useful prognostic biomarkers in NMIBC." @default.
- W4387617103 created "2023-10-14" @default.
- W4387617103 creator A5023882605 @default.
- W4387617103 creator A5024219922 @default.
- W4387617103 creator A5026344581 @default.
- W4387617103 creator A5033835818 @default.
- W4387617103 creator A5056720557 @default.
- W4387617103 date "2023-10-13" @default.
- W4387617103 modified "2023-10-15" @default.
- W4387617103 title "Somatic Mutation of the Non-Muscle-Invasive Bladder Cancer Associated with Early Recurrence" @default.
- W4387617103 cites W1572827793 @default.
- W4387617103 cites W2051120695 @default.
- W4387617103 cites W2105935489 @default.
- W4387617103 cites W2106037418 @default.
- W4387617103 cites W2131117209 @default.
- W4387617103 cites W2152061559 @default.
- W4387617103 cites W2152206210 @default.
- W4387617103 cites W2339422318 @default.
- W4387617103 cites W2419558864 @default.
- W4387617103 cites W2426844253 @default.
- W4387617103 cites W2443056117 @default.
- W4387617103 cites W2471011913 @default.
- W4387617103 cites W2585769337 @default.
- W4387617103 cites W2609464379 @default.
- W4387617103 cites W2621022579 @default.
- W4387617103 cites W2747045298 @default.
- W4387617103 cites W2768235844 @default.
- W4387617103 cites W2783375881 @default.
- W4387617103 cites W2806041148 @default.
- W4387617103 cites W2900589755 @default.
- W4387617103 cites W2941234504 @default.
- W4387617103 cites W3005921595 @default.
- W4387617103 cites W3015039969 @default.
- W4387617103 cites W3153221280 @default.
- W4387617103 cites W3165802010 @default.
- W4387617103 cites W3198719997 @default.
- W4387617103 cites W3207444727 @default.
- W4387617103 cites W3211488171 @default.
- W4387617103 cites W3217485783 @default.
- W4387617103 cites W4200305543 @default.
- W4387617103 cites W4210829812 @default.
- W4387617103 doi "https://doi.org/10.3390/diagnostics13203201" @default.
- W4387617103 hasPublicationYear "2023" @default.
- W4387617103 type Work @default.
- W4387617103 citedByCount "0" @default.
- W4387617103 crossrefType "journal-article" @default.
- W4387617103 hasAuthorship W4387617103A5023882605 @default.
- W4387617103 hasAuthorship W4387617103A5024219922 @default.
- W4387617103 hasAuthorship W4387617103A5026344581 @default.
- W4387617103 hasAuthorship W4387617103A5033835818 @default.
- W4387617103 hasAuthorship W4387617103A5056720557 @default.
- W4387617103 hasBestOaLocation W43876171031 @default.
- W4387617103 hasConcept C121608353 @default.
- W4387617103 hasConcept C126322002 @default.
- W4387617103 hasConcept C142724271 @default.
- W4387617103 hasConcept C143998085 @default.
- W4387617103 hasConcept C156957248 @default.
- W4387617103 hasConcept C2779438470 @default.
- W4387617103 hasConcept C2780352672 @default.
- W4387617103 hasConcept C71924100 @default.
- W4387617103 hasConcept C90924648 @default.
- W4387617103 hasConceptScore W4387617103C121608353 @default.
- W4387617103 hasConceptScore W4387617103C126322002 @default.
- W4387617103 hasConceptScore W4387617103C142724271 @default.
- W4387617103 hasConceptScore W4387617103C143998085 @default.
- W4387617103 hasConceptScore W4387617103C156957248 @default.
- W4387617103 hasConceptScore W4387617103C2779438470 @default.
- W4387617103 hasConceptScore W4387617103C2780352672 @default.
- W4387617103 hasConceptScore W4387617103C71924100 @default.
- W4387617103 hasConceptScore W4387617103C90924648 @default.
- W4387617103 hasIssue "20" @default.
- W4387617103 hasLocation W43876171031 @default.
- W4387617103 hasOpenAccess W4387617103 @default.
- W4387617103 hasPrimaryLocation W43876171031 @default.
- W4387617103 hasRelatedWork W1522132782 @default.
- W4387617103 hasRelatedWork W2002325000 @default.
- W4387617103 hasRelatedWork W2100125829 @default.
- W4387617103 hasRelatedWork W2160411124 @default.
- W4387617103 hasRelatedWork W2898558914 @default.
- W4387617103 hasRelatedWork W2943930186 @default.
- W4387617103 hasRelatedWork W2944005863 @default.
- W4387617103 hasRelatedWork W3009186173 @default.
- W4387617103 hasRelatedWork W3127976301 @default.
- W4387617103 hasRelatedWork W4237262135 @default.
- W4387617103 hasVolume "13" @default.
- W4387617103 isParatext "false" @default.
- W4387617103 isRetracted "false" @default.
- W4387617103 workType "article" @default.